Evidence map›Paper›PMID 41942516›Full record

ArticleScientific data2026

Long non-coding RNA profiling of hypertrophic cardiomyopathy in mice.

Graham A Branscom, Michael P Morley, Jonathan J Herrera, Jaime M Yob, Sharlene M Day

Abstract readDataset
In one paragraph

Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Graham A BranscomCardiology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. graham.branscom@icahn.mssm.edu.ORCID 0009-0000-3144-9191
Michael P MorleyCardiology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jonathan J HerreraDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Jaime M YobCardiology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Sharlene M DayCardiology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Funding

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01- HL-167524U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01-HL-168841U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R33-HL-164376
6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) are transcripts that do not typically code for protein but have essential roles in the regulation of transcription and translation in health and disease. Hypertrophic cardiomyopathy (HCM) is a commonly inherited cardiovascular disease. While a number of studies have described transcriptional regulation in human heart tissue and animal models of HCM, whether lncRNA plays a role in the pathophysiology of HCM remains unknown. We present an RNA-Seq dataset on left ventricle samples from transgenic HCM TNNT2 ∆160 mice (n = 31) and non-transgenic (n = 33) mice (n = 64 total) in which differentially expressed lncRNAs are delineated. We determined the mouse lncRNA genes that have a human ortholog, which may be useful for future investigators aiming to study the role of particular lncRNAs in human HCM.

Indexed as

Cardiomyopathy, HypertrophicRNA, Long NoncodingAnimalsGene Expression ProfilingHumansMiceMice, TransgenicRNA, Long Noncoding

Identifiers

PMID41942516
PMCPMC13230700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.